4888.T JPX
Stella Pharma Corporation
1W: -0.5%
1M: +18.3%
3M: +37.0%
YTD: +23.8%
1Y: +5.7%
3Y: +32.3%
5Y: -25.9%
¥450.00 ($2.85)
+24.00 (+5.63%)
Weekly Expected Move ±6.2%
¥373
¥400
¥426
¥452
¥479
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap¥15.3B ($97.0M)
52W Range200-995
Volume299,500
Avg Volume376,877
Beta0.30
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKoki Uehara
Employees47
SectorHealthcare
IndustryBiotechnology
IPO Date2021-04-22
Websitestella-pharma.co.jp
ORIX Kouraibashi Building
Osaka, OS 541-0043
JP
Osaka, OS 541-0043
JP
81 6 4707 1516
About Stella Pharma Corporation
Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
Latest News
No recent news
Recent Insider Trades
No insider trades found